--Worst 10 day stretch since the 10 days ending May 23, 2025, when it fell 9.17% --Down 46.25% from its all-time closing high of $113.45 on July 29, 2015 --Up 5.19% from 52 weeks ago (July 23, 2024), ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...